• Home
  • > Media & Investors
  • > Media Relations
  • > Press Releases
  • > Daiichi Sankyo Announces Continuation of Mobile Healthcare Field Clinic Service Aimed at Improving Healthcare Access in Tanzania

For Immediate Release

2017.02.02

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: George Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com

Daiichi Sankyo Announces Continuation of Mobile Healthcare Field Clinic Service Aimed at Improving Healthcare Access in Tanzania

TOKYO, Japan (February 2, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it will continue its mobile healthcare field clinic service in Tanzania in cooperation with Plan International Japan.

 

Daiichi Sankyo has operated mobile healthcare field clinics for five years since 2011 in the Kisarawe District, an area with limited healthcare access in Tanzania, in an effort to address high infant and maternal mortality rates. The project has helped improve the immunization rate among infants under one year old from 75% to 91% and the rate of pregnant women who received antenatal care from 34% to 71%.

 

As issues still persist in certain areas of Tanzania, Daiichi Sankyo has decided to continue the mobile healthcare field clinic project in the Kilombero District. The project will further contribute to achieving Sustainable Development Goal No.3 set by the United Nations of ensuring healthy lives and promoting well-being for all ages.

 

 

Overview of the mobile healthcare field clinic service:

1. Activities: Providing healthcare services in regions with limited healthcare access through the use of specialized vehicles

2. Services provided: Immunizations, maternal & child health services, health education etc.

3. Goals: Improvement of immunization rates among infants under one year old and the rate of women who receive antenatal care

4. Period of time: 3 years

5. Total monetary contribution: Approximately 50 million yen (over three years)

6. Partner: Plan International Japan

As a global pharmaceutical company, Daiichi Sankyo is continuously working to improve healthcare access in developing countries. Daiichi Sankyo’s other projects include training healthcare workers and providing healthcare education to local residents in the Yunnan province of China and promoting global healthcare R&D efforts.

 

 

About Plan International Japan

Plan International is an independent child rights and humanitarian organization committed to children living a life free of poverty, violence and injustice. Plan International Japan was founded in Japan in 1983. The organization raise funds in Japan to implement projects in across the world, in addition, makes a collaboration with numerous institutions, organizations, corporations and schools, and implements development of education and advocacy activities in Japan.

https://www.plan-international.jp/

 

About Sustainable Development Goals

Sustainable Development Goals (SDGs) are a set of 17 global goals, with 169 associated targets, which form the 2030 Development Agenda adopted by the United Nations General Assembly in September 2015.